BIOGRAPHY
Michael Nussbaum has over 25 years of experience representing privately held and publicly traded clients in international and trans-national deals, in all aspects of the hi-tech and biotech industries, including start-ups and venture capital, corporate finance, M&A, IP licensing, tech transfer, manufacturing chains, and fund formation.
His work includes advising investors, entrepreneurs, and corporations primarily in the hi-tech, biotech, and life sciences industries, on a broad range of matters from corporate governance, fund formation, corporate finance, and M&A to the nuts and bolts of the clients’ business – licensing, consultancy, joint development arrangements, contract manufacturing, distribution, sales, etc.
Michael’s clients range from start-up companies to Fortune 500 companies. He represents global corporations, as well as mid-size companies, private companies, technology transfer offices of academic institutions, venture capital and private equity funds, and start-up companies in the areas of AI, distributed computing, IOT and telecommunications, fintech, biotechnology, pharmaceuticals, medical devices, materials, and nanotechnology, as well as BTB, consumer software and electronics.
